113 related articles for article (PubMed ID: 2533150)
1. Zoladex in the treatment of premenopausal metastatic breast cancer patients.
Kaufmann M
Horm Res; 1989; 32 Suppl 1():202-5. PubMed ID: 2533150
[TBL] [Abstract][Full Text] [Related]
2. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
[TBL] [Abstract][Full Text] [Related]
3. A multi-centre randomised study to compare the effects of ovarian ablation with Zoladex depot in pre- and perimenopausal patients with advanced breast cancer.
Tyrrell C
Horm Res; 1989; 32 Suppl 1():218-20. PubMed ID: 2533154
[TBL] [Abstract][Full Text] [Related]
4. Zoladex in advanced breast cancer.
Robertson JF; Nicholson RI; Walker KJ; Blamey RW
Horm Res; 1989; 32 Suppl 1():206-8. PubMed ID: 2533151
[TBL] [Abstract][Full Text] [Related]
5. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H
Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149
[TBL] [Abstract][Full Text] [Related]
6. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI
Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044
[TBL] [Abstract][Full Text] [Related]
7. Endocrinology of Zoladex in postmenopausal women.
Dowsett M; Cantwell BM; Harris AL
Horm Res; 1989; 32 Suppl 1():209-12. PubMed ID: 2533152
[TBL] [Abstract][Full Text] [Related]
8. Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
Shaw RW
Prog Clin Biol Res; 1990; 323():383-92. PubMed ID: 2137621
[TBL] [Abstract][Full Text] [Related]
9. LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study).
Bianco AR; Rosso R; Calabresi F; Fiorentino M; Lopez M; Sismondi PG; Lenti R; Fosser V; De Placido S; Perrone F
Eur J Gynaecol Oncol; 1991; 12(6):429-37. PubMed ID: 1839730
[TBL] [Abstract][Full Text] [Related]
10. A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Emtage LA; Trethowan C; Kelly K; Arkell D; Wallace DM; Hughes M; Hay A; Blacklock R; Jones M; Rouse A
Prog Clin Biol Res; 1989; 303():47-52. PubMed ID: 2528739
[No Abstract] [Full Text] [Related]
11. Goserelin depot in the treatment of premenopausal advanced breast cancer.
Blamey RW; Jonat W; Kaufmann M; Bianco AR; Namer M
Eur J Cancer; 1992; 28A(4-5):810-4. PubMed ID: 1388037
[TBL] [Abstract][Full Text] [Related]
12. [Therapy with gonadotropin releasing hormone agonists (zoladex) in premenopausal females with metastastic breast cancer].
Kaufmann M; Schmid H; Kiesel L; Klinga K
Geburtshilfe Frauenheilkd; 1988 Jul; 48(7):528-32. PubMed ID: 2975241
[TBL] [Abstract][Full Text] [Related]
13. LHRH analogue for treatment of recurrent and refractory mastalgia.
Hamed H; Caleffi M; Chaudary MA; Fentiman IS
Ann R Coll Surg Engl; 1990 Jul; 72(4):221-4. PubMed ID: 2143364
[TBL] [Abstract][Full Text] [Related]
14. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
Reichel RP; Schweppe KW
Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
[TBL] [Abstract][Full Text] [Related]
15. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
Peeling WB
Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
[No Abstract] [Full Text] [Related]
16. Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex.
Robert NJ; Dalton WS; Osborne CK; Abeloff M
Horm Res; 1989; 32 Suppl 1():221-2. PubMed ID: 2533155
[TBL] [Abstract][Full Text] [Related]
17. Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
Dixon AR; Robertson JF; Jackson L; Nicholson RI; Walker KJ; Blamey RW
Br J Cancer; 1990 Nov; 62(5):868-70. PubMed ID: 2147110
[TBL] [Abstract][Full Text] [Related]
18. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
[No Abstract] [Full Text] [Related]
19. The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Stein RC; Dowsett M; Hedley A; Gazet JC; Ford HT; Coombes RC
Br J Cancer; 1990 Oct; 62(4):679-83. PubMed ID: 2145964
[TBL] [Abstract][Full Text] [Related]
20. A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot.
Dijkman GA; Fernandez del Moral P; Plasman JW; Pull HC; van der Meijden AP; Debruyne FM; Hutchinson FG; Furr BJ
Eur Urol; 1990; 18 Suppl 3():22-5. PubMed ID: 2151271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]